Technical Data
E2280-02
Encephalitis, Eastern Equine (EEE)
Description:
Eastern Equine Encephalitis is caused by Eastern Equine Encephalitis virus, a mosquito-borne virus. It is capable of infecting a wide range of animals including mammals, birds, reptiles and amphibians. The virus is maintained in nature through a bird-mosquito cycle.

Applications:
Suitable for use in Indirect Immunofluorescence, ELISA and Hemagglutination Inhibition. Other applications not tested.

Recommended Dilutions:
Optimal dilutions to be determined by the researcher.

Storage and Stability:
May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
TypeIsotypeCloneGrade
MabIgG2b2Q1908Purified
SizeStorageShippingSourceHost
100ug-20°CBlue IceMouse
Concentration:
~1mg/ml
Immunogen:
Purity:
Purified
Form
Supplied as a liquid in 0.02M PBS, pH 7.6, 0.1% sodium azide.
Specificity:
Recognizes Encephalitis, Eastern Equine (EEE). Encephalitis Virus Strains Indentified: Eastern Equine (EEE) N. American eastern equine (NJ/60); S. American eastern equine (BeAn 5122) Western Equine (WEE) Western equine (McMIllan); Highlands J (B-230); Sindbis Semliki Forest Venezuelan Equine (VEE) 1AB (TC-83 Vaccine, Trinidad Donkey, PTF-39); 1C (P676); 1D (3880); 1E (Mena II); 1F(78V-3531); (Fe3-7c); (Mucambo); (Pixuna); (Cabassou)
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.